Mercado mundial de tratamiento del queratocono: tendencias de la industria y pronóstico hasta 2030

Análisis y tamaño del mercado de tratamiento del queratocono

El aumento de casos de trastornos oculares impulsa el mercado de tratamiento del queratocono. La sobreexposición a los rayos UV del sol y también el desequilibrio enzimático en la córnea que aumenta el riesgo de aparición de trastornos oculares impulsan el crecimiento del mercado de tratamiento del queratocono. Según el American Journal of Ophthalmology, entre 50 y 200 de cada 100.000 personas padecen queratocono. Los principales actores del mercado que operan en el mercado de tratamiento del queratocono están invirtiendo enormemente en I+D para desarrollar soluciones eficientes para el queratocono.

 Data Bridge Market Research analiza la tasa de crecimiento del mercado de tratamiento del queratocono en el período de pronóstico 2023-2030. La CAGR esperada del mercado de tratamiento del queratocono tiende a rondar el 4,2% en el período de pronóstico mencionado. El mercado está valorado en USD 280,36 millones en 2022 y crecería hasta USD 389,64 millones para 2030. Además de los conocimientos del mercado, como el valor de mercado, la tasa de crecimiento, los segmentos del mercado, la cobertura geográfica, los actores del mercado y el escenario del mercado, el informe de mercado curado por el equipo de Data Bridge Market Research también incluye un análisis profundo de expertos, epidemiología del paciente, análisis de la cartera, análisis de precios y marco regulatorio.

Alcance y segmentación del mercado del tratamiento del queratocono

Market Definition

Keratoconus is a progressive type of eye disease that causes thinning of cornea and alters the cornea into dome or cone like shape. Keratoconus also changes the vision that cannot be corrected with the eye-glasses. The symptoms of keratoconus include nearsightedness, light sensitivity, blurred vision, and irregular astigmatism. Treatment for keratoconus disorder highly depends on the severity of condition and how rapidly the progression of the condition takes place. Mild to moderate keratoconus can be widely treated with contact lenses or eyeglasses.

Global Keratoconus Treatment Market Dynamics

Drivers

• Increasing Incidence of Keratoconus Disorder

There has been a rise in cases with keratoconus disorder worldwide. The increasing occurrence and incidence of keratoconus disorders also surge the demand for various treatment options such as lenses, surgeries, and corneal cross-linking. According to the American Journal of Ophthalmology records, about 50-200 of every 100,000 people are suffering from keratoconus. In the U.S., around 54.5 per 100,000 people were affected with this disease. In addition to this, around 3 million people are affected by this disease globally. Therefore, rising keratoconus cases boost the use of different treatment methods such as intacs and corneal transplants, boosting market growth.

• Rising Ultraviolet Radiations and Sun Exposure

As per the study titled “Epidemiology of Keratoconus Worldwide” by the Open Opthalmology Journal, ultraviolet radiation is considered as one of the primary causes for the development of keratoconus due to its oxidative damage. This can be demonstrated by its high occurrence of keratoconus in hot and sunny areas. Higher incidence of keratoconus has been witnessed in Saudi Arabia, Iran, New Zealand, Israel, and some Pacific Islands. This is due to the high exposure to the sun and UV rays. Therefore, ultraviolet radiations and sun exposure are most likely to cause keratoconus disorder, thus boosting the keratoconus treatment market.

Opportunities

• Increasing Product Launches and Developments

Increasing number of approvals by the FDA for numerous new drugs and treatments for keratoconus boosts the growth of the keratoconus treatment market. For instance, Bausch + Lomb received 510(k) clearance for the Tangible Hydra-PEG Custom Contact Lens Coating Technology on Boston Gas Permeable Lens Materials and Zenlens Family of Scleral Lenses in February 2019. With this coating technology, several eye care practitioners have the opportunity to improve contact lens customization for their patients using these Bausch + Lomb lens offerings. Furthermore, Bausch + Lomb announced that its Specialty Vision Products business launched the Zenlens diagnostic lenses in a new 28 lens set format in December 2016. Adding to it, the new 28 lens set adds four diagnostic lenses with toric peripheral curves. Therefore, all these advancements provide lucrative growth opportunities to the market players.

• Growing Treatment Options for Keratoconus Patients

The current treatment option, which includes cornea cross-linking, intrastromal corneal ring segments, and other combined treatments, provides the corneal clinicians a variety of treatment options for the visual rehabilitation of keratoconus patients. In patients with mild issue, eyeglasses or soft contact lenses are preferred. But as the disease evolves and the cornea thins and becomes irregular in shape, and in that case, glasses and regular soft contact lens no longer offers accurate vision correction. Some other treatment options include corneal collagen custom soft contact lenses, cross-linking or CXL, gas permeable contact lenses. Thus, this factor boosts the market growth.

Restraints/Challenges

• Lack of Awareness

Numerous eye-related problems develop very slowly and are caused because of carelessness. Some of these problems are minimal, while some need special treatments that are expensive. In highly developing regions, a large number of people do not have enough expenditure to avail treatment for these diseases. Furthermore, many of them have inadequate knowledge about such diseases that, further increases the severity. According to the National Keratoconus Foundation, keratoconus occurs in around 1 out of every 2,000 people among the general population. Keratoconus is not very common and thus there is less awareness among the public in spite of their noisome symptoms and complications. The lack of knowledge which leads to the loss in timely management of keratoconus treatments hamper the market growth.  

This keratoconus treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the keratoconus treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Keratoconus Treatment Market

COVID-19 left a major impact on the market growth. Manufacturing, local business, and investment have been severely affected by social and economic factors. The COVID-19 pandemic impacted the keratoconus treatment market and its financial capability. It also affected the capability of several companies to evaluate capital, which severely impacted their short-term and long-term liquidity. For instance, the revenue of Bausch Health had declined by more than 35% in 2020 because of COVID-19. But, in the post pandemic era, the recession has been waived off, and the companies are splurging on the product launches and increased developments that boost market growth.

Global Keratoconus Treatment Market Scope

The keratoconus treatment market is segmented on the basis of keratoconus type, treatment, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Keratoconus Type

• Corneal Hydrops
• Forme Fruste Keratoconus
• Posterior Keratoconus
• Keratoglobus
• Pellucid Marginal Degeneration

Treatment

• Lenses
• Therapies
• Surgery
• Others

Route of Administration

• Oral
• Topical
• Parenteral
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Keratoconus Treatment Market Regional Analysis/Insights

The keratoconus treatment market is analyzed and market size insights and trends are provided by keratoconus type, treatment, route of administration, end-users and distribution channel as referenced above.

Los principales países cubiertos en el informe del mercado de tratamiento del queratocono  son EE. UU., Canadá y México en América del Norte, Alemania, Francia, Reino Unido, Países Bajos, Suiza, Bélgica, Rusia, Italia, España, Turquía, Resto de Europa en Europa, China, Japón, India, Corea del Sur, Singapur, Malasia, Australia, Tailandia, Indonesia, Filipinas, Resto de Asia-Pacífico (APAC) en Asia-Pacífico (APAC), Arabia Saudita, Emiratos Árabes Unidos, Sudáfrica, Egipto, Israel, Resto de Medio Oriente y África (MEA) como parte de Medio Oriente y África (MEA), Brasil, Argentina y Resto de América del Sur como parte de América del Sur.

Durante el período previsto, América del Norte ha experimentado un crecimiento positivo del mercado de tratamiento del queratocono debido al enfoque de los principales actores del mercado en tecnologías novedosas o formulaciones de medicamentos existentes. La mayor conciencia y los avances en la tecnología también están impulsando aún más el crecimiento del mercado.

La región de Asia-Pacífico domina el mercado debido a la alta incidencia de casos de trastornos oculares y a la cantidad de medicamentos genéricos, así como a la gran cantidad de fusiones y adquisiciones y aprobaciones de productos en la región. Por ejemplo, Hoya Corporation inauguró un centro de I+D para lentes intraoculares para cataratas en Singapur en enero de 2018.

La sección de países del informe también proporciona factores de impacto individuales en el mercado y cambios en la regulación del mercado a nivel nacional que afectan las tendencias actuales y futuras del mercado. Además, se consideran la presencia y disponibilidad de marcas globales y los desafíos que enfrentan debido a la gran o escasa competencia de las marcas locales y nacionales, el impacto de los aranceles nacionales y las rutas comerciales, al tiempo que se proporciona un análisis de pronóstico de los datos del país.   

Análisis del panorama competitivo y de la cuota de mercado global del tratamiento del queratocono

El panorama competitivo del mercado de tratamiento del queratocono proporciona detalles por competidor. Los detalles incluidos son una descripción general de la empresa, las finanzas de la empresa, los ingresos generados, el potencial de mercado, la inversión en investigación y desarrollo, las nuevas iniciativas de mercado, la presencia global, los sitios e instalaciones de producción, las capacidades de producción, las fortalezas y debilidades de la empresa, el lanzamiento de productos, la amplitud y variedad de productos, el dominio de la aplicación. Los puntos de datos anteriores proporcionados solo están relacionados con el enfoque de las empresas en relación con el mercado de tratamiento del queratocono.

Los actores clave que operan en el mercado del tratamiento del queratocono incluyen:

• Sandoz International GmbH (Alemania)
• HOYA (Japón)
• Menicon Co., Ltd. (Japón)
• The Cooper Companies, Inc. (Estados Unidos)
• Bausch Health Companies Inc. (Canadá)
• SynergEyes (Estados Unidos)
• Carl Zeiss Meditec AG (Alemania)
• Contamac (Reino Unido)
• SEED Co., Ltd (Japón)
• Novartis AG (Suiza)
• Johnson & Johnson Services, Inc. (Estados Unidos)

SKU-52890